Select a medication above to begin.
Aliqopa
copanlisib
Adult Dosing .
Dosage forms: INJ
Withdrawn from US Market
- [March 31, 2024]
- Info: voluntary withdrawal due to lack of efficacy in pts w/ relapsed follicular lymphoma; physician may register pts currently having objective favorable response for expanded access program (EAP); EAP will close on 12/31/2026; www.clinigengroup.com or medicineaccess@clinigengroup.com for more info
Peds Dosing .
- Dosage forms: --
Withdrawn from US Market
- [March 31, 2024]
- Info: voluntary withdrawal due to lack of efficacy in pts w/ relapsed follicular lymphoma; physician may register pts currently having objective favorable response for expanded access program (EAP); EAP will close on 12/31/2026; www.clinigengroup.com or medicineaccess@clinigengroup.com for more info